Low density lipoprotein receptor-related protein 5 (LRP5) mutations and osteoporosis, impaired glucose metabolism and hypercholesterolaemia

Clinical Endocrinology

Volumn 72, Issue 4, 2010, Pages 481-488

  Mäkitie, Outi ^a,b   Saarinen, Anne ^a,b   Saukkonen, Tero ^b   Kivelä, Tero ^c   Lahtinen, Ulla ^a,b   Laine, Christine ^a,b   Somer, Mirja ^d   Toiviainen Salo, Sanna ^c   Cole, William G ^e   Lehesjoki, Anna Elina ^a,b  

^a FOLKHÄLSAN INSTITUTE OF GENETICS   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^d Family Federation of Finland ^*  (Finland)

^e HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; LIPID; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN 5; SEROTONIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BONE; BONE DENSITY; CELL FUNCTION; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIABETES MELLITUS; DISORDERS OF CARBOHYDRATE METABOLISM; FEMALE; FEMUR NECK; FINLAND; GLUCOSE BLOOD LEVEL; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HUMAN CELL; HYPERCHOLESTEROLEMIA; LIPID BLOOD LEVEL; LIPID METABOLISM; LUMBAR SPINE; MALE; MORPHOLOGY; MUTATION; NUCLEOTIDE SEQUENCE; ORAL GLUCOSE TOLERANCE TEST; OSTEOPOROSIS; PREVALENCE; PRIORITY JOURNAL; SEROTONIN BLOOD LEVEL; SPINE FRACTURE; VERTEBRA; VERTEBRA FRACTURE;

ADOLESCENT; ADULT; AGED; AMINO ACID SEQUENCE; BONE DENSITY; FEMALE; FEMUR NECK; GLIOMA; GLUCOSE INTOLERANCE; HUMANS; HYPERCHOLESTEROLEMIA; LDL-RECEPTOR RELATED PROTEINS; LIPID METABOLISM; LUMBAR VERTEBRAE; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION; OSTEOPOROSIS; SYNDROME;

EID: 77749301445     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2009.03680.x     Document Type: Article

References (30)

1. Gong, Y., Slee, R.B., Fukai, N. et al. (2001) LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell, 107, 513 523.
2. Frontali, M., Stomeo, C. Dallapiccola, B. (1985) Osteoporosis- pseudoglioma syndrome: report of three affected sibs and an overview. American Journal of Medical Genetics, 22, 35 47.
3. Beighton, P. (1986) Osteoporosis-pseudoglioma syndrome. Clinical Genetics, 29, 263.
4. De Paepe, A., Leroy, J.G., Nuytinck, L. et al. (1993) Osteoporosis-pseudoglioma syndrome. American Journal of Medical Genetics, 45, 30 37.
5. Little, R.D., Carulli, J.P., Del Mastro, R.G. et al. (2002) A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait. American Journal of Human Genetics, 70, 11 19.
6. Boyden, L.M., Mao, J., Belsky, J. et al. (2002) High bone density due to a mutation in LDL-receptor-related protein 5. New England Journal of Medicine, 346, 1513 1521.
7. Lev, D., Binson, I., Foldes, A.J. et al. (2003) Decreased bone density in carriers and patients of an Israeli family with the osteoporosis-pseudoglioma syndrome. Israel Medical Association Journal, 5, 419 421.
8. Hartikka, H., Makitie, O., Mannikko, M. et al. (2005) Heterozygous mutations in the LDL receptor-related protein 5 (LRP5) gene are associated with primary osteoporosis in children. Journal of Bone and Mineral Research, 20, 783 789.
9. Crabbe, P., Balemans, W., Willaert, A. et al. (2005) Missense mutations in LRP5 are not a common cause of idiopathic osteoporosis in adult men. Journal of Bone and Mineral Research, 20, 1951 1959.
10. Saarinen, A., Valimaki, V.V., Valimaki, M.J. et al. (2007) The A1330V polymorphism of the low-density lipoprotein receptor-related protein 5 gene (LRP5) associates with low peak bone mass in young healthy men. Bone, 40, 1006 1012.
11. Koay, M.A., Tobias, J.H., Leary, S.D. et al. (2007) The effect of LRP5 polymorphisms on bone mineral density is apparent in childhood. Calcified Tissue International, 81, 1 9.
12. Xiong, D.H., Lei, S.F., Yang, F. et al. (2007) Low-density lipoprotein receptor-related protein 5 (LRP5) gene polymorphisms are associated with bone mass in both Chinese and whites. Journal of Bone and Mineral Research, 22, 385 393.
13. Ai, M., Heeger, S., Bartels, C.F. et al. (2005) Clinical and molecular findings in osteoporosis-pseudoglioma syndrome. American Journal of Human Genetics, 77, 741 753.
14. Kato, M., Patel, M.S., Levasseur, R. et al. (2002) Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a wnt coreceptor. Journal of Cell Biology, 157, 303 314.
15. Fujino, T., Asaba, H., Kang, M.J. et al. (2003) Low-density lipoprotein receptor-related protein 5 (LRP5) is essential for normal cholesterol metabolism and glucose-induced insulin secretion. Proceedings of the National Academy of Sciences of the United States of America, 100, 229 234.
16. Guo, Y.F., Xiong, D.H., Shen, H. et al. (2006) Polymorphisms of the low-density lipoprotein receptor-related protein 5 (LRP5) gene are associated with obesity phenotypes in a large family-based association study. Journal of Medical Genetics, 43, 798 803.
17. Suwazono, Y., Kobayashi, E., Uetani, M. et al. (2006) G-protein beta 3 subunit polymorphism C1429T and low-density lipoprotein receptor-related protein 5 polymorphism A1330V are risk factors for hypercholesterolemia in japanese males - a prospective study over 5 years. Metabolism, 55, 751 757.
18. Suwazono, Y., Kobayashi, E., Uetani, M. et al. (2006) Low-density lipoprotein receptor-related protein 5 variant Q89R is associated with hypertension in japanese females. Blood Pressure, 15, 80 87.
19. Suwazono, Y., Kobayashi, E., Uetani, M. et al. (2006) Low-density lipoprotein receptor-related protein 5 variant A1330V is a determinant of blood pressure in japanese males. Life Sciences, 78, 2475 2479.
20. Mani, A., Radhakrishnan, J., Wang, H. et al. (2007) LRP6 mutation in a family with early coronary disease and metabolic risk factors. Science, 315, 1278 1282.
21. Yadav, V.K., Ryu, J.H., Suda, N. et al. (2008) Lrp5 controls bone formation by inhibiting serotonin synthesis in the duodenum. Cell, 135, 825 837.
22. Somer, H., Palotie, A., Somer, M. et al. (1988) Osteoporosis-pseudoglioma syndrome: clinical, morphological, and biochemical studies. Journal of Medical Genetics, 25, 543 549.
23. Genant, H.K., Wu, C.Y., van Kuijk, C. et al. (1993) Vertebral fracture assessment using a semiquantitative technique. Journal of Bone and Mineral Research, 8, 1137 1148.
24. Alberti, K.G. Zimmet, P.Z. (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabetic Medicine, 15, 539 553.
25. Greenbaum, C.J., Cuthbertson, D., Krischer, J.P. et al. (2001) Type I diabetes manifested solely by 2-h oral glucose tolerance test criteria. Diabetes, 50, 470 476.
26. Matthews, D.R., Hosker, J.P., Rudenski, A.S. et al. (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 28, 412 419.
27. Stern, S.E., Williams, K., Ferrannini, E. et al. (2005) Identification of individuals with insulin resistance using routine clinical measurements. Diabetes, 54, 333 339.
28. Fajans, S.S., Bell, G.I. Polonsky, K.S. (2001) Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young. New England Journal of Medicine, 345, 971 980.
29. Figueroa, D.J., Hess, J.F., Ky, B. et al. (2000) Expression of the type I diabetes-associated gene LRP5 in macrophages, vitamin A system cells, and the islets of langerhans suggests multiple potential roles in diabetes. Journal of Histochemistry and Cytochemistry, 48, 1357 1368.
30. Twells, R.C., Mein, C.A., Payne, F. et al. (2003) Linkage and association mapping of the LRP5 locus on chromosome 11q13 in type 1 diabetes. Human Genetics, 113, 99 105.